Skin manifestations of inflammatory bowel diseases
https://doi.org/10.31146/1682-8658-ecg-175-3-113-117
Abstract
The urgency of inflammatory bowel diseases increases every year as the prevalence of pathology in the world increases. Unlike most diseases, inflammatory bowel diseases do not always debut classic intestinal symptoms, often in the debut of pathology — extraintestinal manifestations.
The article describes three clinical cases of patients with IBD and skin manifestations, different outcomes and management tactics.
About the Authors
M. M. KudishinaRussian Federation
Mariya M. Kudishina, Department of Therapy, Gastroenterology and Pulmonology, Assistant of Professor
Saratov
I. V. Kozlova
Russian Federation
Irina V. Kozlova, Department of Therapy, Gastroenterology and Pulmonology, Professor, MD, Head of department
Saratov
E. A. Yavaeva
Russian Federation
gastroenterologist
Saratov
References
1. Knyazev O. V., Shkurko T. V., Fadeeva N. A. et al. Epidemiology of chronic inflammatory bowel diseases. Yesterday, today, tomorrow. Experimental & clinical gastroenterology. 2017; 3(139): 4–12.
2. Kliaritskaia I. L., Stilidi E. I., Maksimova E. V. et al. Extraintestinal manifestations of inflammatory bowel disease. Crimean Journal of Internal Diseases. 2017; 1(32): 47–51.
3. Zhilin S. A., Radchenko V. G., Dobritsa V. P. Extra in testinal manifestations of inflammatory bowel disease. Herald of North-Western state medical university named aft er I. I. Mechnikov. 2013; 5(2):111–117.
4. Harbord M., Annese V., Vavrica S. R. et al. The First evidence-based consensus on extra-intestinal manifestations in inflammatory bowel disease. Journal of Crohn’s and colitis. 2016; 10(3): 239–254.
5. Zippi M., Pica R., De Nitto D. et al. Biological therapy for dermatological manifestations of inflammatory bowel disease. World journal of clinical cases. 2013; 1(2): 74–78.
6. Bernstein C.N., Blanchard J. F., Rawsthorne P. et al. The prevalence of extraintestinal diseases in inflammatory bowel disease: a population-based study. American journal of gastroenterology. 2001; 96: 1116–1122.
7. Alavi A., French L. E., Davis M. D. et al. Pyoderma gangrenosum: an update on pathophysiology, diagnosis and treatment. American journal of clinical dermatology. 2017; 18(3): 355–372.
8. Brodell D.W., Elfar J. C., Mercurio M. G. Pyoderma gangrenosum and inflammatory bowel disease: A cross-sectional inpatient socioeconomic study. Journal of the American academy of Dermatology. 2015; 73(5): 877–880.
9. Tomioka T., Soma K., Sato Y. et al. Pyoderma gangrenosum on the nose. Auris, nasus, larynx. 2018; 45(5): 1130–1134.
10. Partridge A.C.R., Bai J. W., Rosen C. F. et al. Effectiveness of systemic treatments for pyoderma gangrenosum: a systematic review of observational studies and clinical trials. The British journal of dermatology. 2018; 179(2): 290–295.
11. Barishnikova E. N., Neiman K. P. Pyodermia gangrenosum in Crohn’s disease. Experimental & clinical gastroenterology. 2008; 5: 92–94.
12. Vavricka S.R., Rogler G., Gantenbein C. et al. Chronolo gical Order of Appearance of Extraintestinal Manifestations Relative to the Time of IBD Diagnosis in the Swiss. Inflammatory Bowel Disease Cohort. inflammatory bowel disease. 2015; 21(8):1794–1780.
13. Trost L.B., McDonell J. K. Important cutaneous manifestations of inflammatory bowel disease. Postgraduate medical journal. 2005; 81(859): 580–585.
14. Timani S., Mutasim D. F. Skin manifestations of inflammatory bowel disease. Clinics in dermatology. 2008; 26(3): 265–273.
15. Orchard T. Extraintestinal complications of inflammatory bowel disease. Current gastroenterology reports. 2003; 5(6): 512–517.
Review
For citations:
Kudishina M.M., Kozlova I.V., Yavaeva E.A. Skin manifestations of inflammatory bowel diseases. Experimental and Clinical Gastroenterology. 2020;(3):113-117. (In Russ.) https://doi.org/10.31146/1682-8658-ecg-175-3-113-117